Braeburn resubmits new drug application for experimental opioid use disorder treatment
June 16, 2021 at 10:44 AM EDT
The FDA in December rejected the company's previous attempt to get the new drug candidate approved.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|